MNOV – Medicinova Inc
Float Short %
1.22
Margin Of Safety %
Put/Call OI Ratio
0.02
EPS Next Q Diff
EPS Last/This Y
-0.27
EPS This/Next Y
0.12
Price
1.51
Target Price
9
Analyst Recom
1
Performance Q
17.97
Relative Volume
0.07
Beta
0.5
Ticker: MNOV
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | MNOV | 1.42 | 0.02 | 999.99 | 1276 |
| 2025-11-11 | MNOV | 1.6 | 0.02 | 0.00 | 1274 |
| 2025-11-12 | MNOV | 1.595 | 0.02 | 0.00 | 1274 |
| 2025-11-13 | MNOV | 1.53 | 0.02 | 0.00 | 1273 |
| 2025-11-14 | MNOV | 1.56 | 0.02 | 0.00 | 1272 |
| 2025-11-17 | MNOV | 1.42 | 0.02 | 0.00 | 1272 |
| 2025-11-18 | MNOV | 1.445 | 0.02 | 0.00 | 1272 |
| 2025-11-19 | MNOV | 1.44 | 0.02 | 0.00 | 1272 |
| 2025-11-20 | MNOV | 1.44 | 0.02 | 0.00 | 1272 |
| 2025-11-21 | MNOV | 1.44 | 0.02 | 999.99 | 1275 |
| 2025-11-24 | MNOV | 1.47 | 0.02 | 999.99 | 1275 |
| 2025-11-25 | MNOV | 1.52 | 0.02 | 0.00 | 735 |
| 2025-11-26 | MNOV | 1.47 | 0.02 | 0.67 | 683 |
| 2025-12-01 | MNOV | 1.42 | 0.02 | 0.00 | 685 |
| 2025-12-02 | MNOV | 1.47 | 0.02 | 0.00 | 684 |
| 2025-12-03 | MNOV | 1.505 | 0.02 | 0.00 | 693 |
| 2025-12-04 | MNOV | 1.545 | 0.02 | 0.00 | 702 |
| 2025-12-05 | MNOV | 1.57 | 0.02 | 0.00 | 710 |
| 2025-12-08 | MNOV | 1.53 | 0.02 | 0.00 | 719 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | MNOV | 1.41 | - | - | -0.50 |
| 2025-11-11 | MNOV | 1.61 | - | - | -0.50 |
| 2025-11-12 | MNOV | 1.58 | - | - | -0.50 |
| 2025-11-13 | MNOV | 1.53 | - | - | -0.50 |
| 2025-11-14 | MNOV | 1.55 | - | - | -0.50 |
| 2025-11-17 | MNOV | 1.41 | -100.0 | - | -0.50 |
| 2025-11-18 | MNOV | 1.44 | -100.0 | - | -0.50 |
| 2025-11-19 | MNOV | 1.43 | -100.0 | - | -0.50 |
| 2025-11-20 | MNOV | 1.44 | -100.0 | - | -0.50 |
| 2025-11-21 | MNOV | 1.43 | -100.0 | - | -0.50 |
| 2025-11-24 | MNOV | 1.47 | -100.0 | - | -0.50 |
| 2025-11-25 | MNOV | 1.52 | -100.0 | - | -0.50 |
| 2025-11-26 | MNOV | 1.46 | -100.0 | - | -0.50 |
| 2025-12-01 | MNOV | 1.42 | -100.0 | - | -0.50 |
| 2025-12-02 | MNOV | 1.47 | -100.0 | - | -0.50 |
| 2025-12-03 | MNOV | 1.51 | -100.0 | - | -0.50 |
| 2025-12-04 | MNOV | 1.54 | -100.0 | - | -0.50 |
| 2025-12-05 | MNOV | 1.56 | -100.0 | - | -0.50 |
| 2025-12-08 | MNOV | 1.51 | -100.0 | - | -0.50 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | MNOV | 0.00 | -0.04 | 0.26 |
| 2025-11-11 | MNOV | 0.00 | -0.04 | 0.26 |
| 2025-11-12 | MNOV | 0.00 | -0.04 | 1.63 |
| 2025-11-13 | MNOV | 0.00 | -0.04 | 1.63 |
| 2025-11-14 | MNOV | 0.00 | -0.04 | 1.63 |
| 2025-11-17 | MNOV | 0.00 | -0.15 | 1.63 |
| 2025-11-18 | MNOV | 0.00 | -0.15 | 1.63 |
| 2025-11-19 | MNOV | 0.00 | -0.15 | 1.63 |
| 2025-11-20 | MNOV | 0.00 | -0.15 | 1.63 |
| 2025-11-21 | MNOV | 0.00 | -0.15 | 1.63 |
| 2025-11-24 | MNOV | 0.00 | -0.11 | 1.63 |
| 2025-11-25 | MNOV | 0.00 | -0.11 | 1.63 |
| 2025-11-26 | MNOV | 0.00 | -0.11 | 1.22 |
| 2025-12-01 | MNOV | 0.00 | -0.06 | 1.22 |
| 2025-12-02 | MNOV | 0.00 | -0.06 | 1.22 |
| 2025-12-03 | MNOV | 0.00 | -0.06 | 1.22 |
| 2025-12-04 | MNOV | 0.00 | -0.06 | 1.22 |
| 2025-12-05 | MNOV | 0.00 | -0.06 | 1.22 |
| 2025-12-08 | MNOV | 0.00 | -0.11 | 1.22 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.06
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-0.11
Beta
0.5
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
21
Growth Score
19
Sentiment Score
91
Actual DrawDown %
86
Max Drawdown 5-Year %
-87.1
Target Price
9
P/E
Forward P/E
PEG
P/S
284.84
P/B
1.68
P/Free Cash Flow
EPS
-0.24
Average EPS Est. Cur. Y
-0.5
EPS Next Y. (Est.)
-0.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-4656.65
Relative Volume
0.07
Return on Equity vs Sector %
-54.2
Return on Equity vs Industry %
-39.3
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
MediciNova, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 13
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
stock quote shares MNOV – Medicinova Inc Stock Price stock today
news today MNOV – Medicinova Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MNOV – Medicinova Inc yahoo finance google finance
stock history MNOV – Medicinova Inc invest stock market
stock prices MNOV premarket after hours
ticker MNOV fair value insiders trading